Minai-Azary Jennifer Lynn
Insider CIK 1844398 · MLND Chief Financial Officer · CNTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTX Context Therapeutics Inc. | A Award deriv | 2026-02-19 | 2026-02-23 | 275,000 | — | $0 | 275,000 | SEC↗ |
| CNTX Context Therapeutics Inc. | P Buy | 2025-06-06 | 2025-06-10 | 40,010 | $0.64 | $25.6K | 80,010 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2025-02-13 | 2025-02-14 | 371,800 | — | $0 | 371,800 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2024-03-21 | 2024-03-22 | 160,115 | — | $0 | 160,115 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2023-02-13 | 2023-02-14 | 158,001 | — | $0 | 158,001 | SEC↗ |
| CNTX Context Therapeutics Inc. | P Buy | 2022-12-16 | 2022-12-19 | 25,000 | $0.74 | $18.5K | 40,000 | SEC↗ |
| CNTX Context Therapeutics Inc. | P Buy | 2022-08-17 | 2022-08-17 | 15,000 | $1.80 | $27.0K | 15,000 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2022-02-25 | 2022-02-25 | 112,470 | — | $0 | 112,470 | SEC↗ |
| CNTX Context Therapeutics Inc. | A Award deriv | 2021-11-01 | 2021-11-01 | 52,753 | — | $0 | 52,753 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2021-02-26 | 2021-03-02 | 110,000 | — | $0 | 110,000 | SEC↗ |